Estimated risk reduction of mortality and transplantation with bezafibrate in patients with PBC and inadequate response to UDCA: application of the UK-PBC and Global PBC risk scores to the BEZURSO trial
(1)
,
(2)
,
(1)
,
(3)
,
(4)
,
(5)
,
(6)
,
(7)
,
(8)
,
(9)
,
(10)
,
(11)
,
(12, 10)
,
(13, 14)
,
(15, 16)
,
(17, 18)
,
(19)
,
(20)
,
(21, 22)
,
(23, 24)
,
(25)
,
(26)
,
(27)
,
(1)
,
(2)
,
(2)
,
(1)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27